Previous Close | 256.68 |
Open | 255.79 |
Bid | 256.67 x 1300 |
Ask | 256.99 x 900 |
Day's Range | 253.90 - 256.91 |
52 Week Range | 202.13 - 256.91 |
Volume | |
Avg. Volume | 5,941,136 |
Market Cap | 526.579B |
Beta (5Y Monthly) | 0.95 |
PE Ratio (TTM) | 30.97 |
EPS (TTM) | 8.28 |
Earnings Date | Jan 24, 2024 - Jan 29, 2024 |
Forward Dividend & Yield | 2.08 (0.81%) |
Ex-Dividend Date | Nov 08, 2023 |
1y Target Est | 278.27 |
Over long periods, dividend stocks tend to outperform their non-dividend-paying counterparts. There are likely several reasons for this, one of which is that sustaining a dividend program requires a solid underlying business. It's a Dividend King with 52 consecutive years of payout hikes -- if you include the time it spent as a unit of Abbott Laboratories.
These stocks have incredible long-term potential and are also benefiting from the current market rally.
Key Insights Significantly high institutional ownership implies Visa's stock price is sensitive to their trading...